The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Triad Isotopes Inc

  • Contact Person: Shannon Julian
  • Contact Phone: 407-455-6717
  • Contact Email: sjulian@triadisotopes.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • For Profit Organization
  • Industries Served: Pharmacies and Drug Stores
  • Product Areas: MEDICAL- PHARMACOLOGY, PHARMACOLOGY SERVICES

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $9,556 - Thursday the 8th of December 2011
    Veterans Affairs Department
    757-COLUMBUS
    CONTRACT 6 MONTH EXTENSION.
  • $93,855 - Friday the 17th of February 2012
    Veterans Affairs Department
    520-BILOXI
    RADIOPHARMACEUTICAL COMPOUNDS, DEOBLIGATE UNUSED FY11 FUNDS.
  • $9,223 - Wednesday the 27th of June 2012
    Veterans Affairs Department
    757-COLUMBUS
    RADIOPHARMACEUTICALS FOR JUNE 2012 FROM TRIAD
  • $9,223 - Monday the 21st of May 2012
    Veterans Affairs Department
    757-COLUMBUS
    RADIOPHARMACEUTICALS FROM TRIAD ISOTOPES FOR MAY 2012
  • $8,884 - Tuesday the 3rd of April 2012
    Veterans Affairs Department
    757-COLUMBUS
    RADIOPHARMACEUTICALS FOR VISN 10
  • $8,574 - Thursday the 16th of February 2012
    Veterans Affairs Department
    552-DAYTON
    MONTHLY ORDER FOR RADIOPHARMACUTICALS FOR NECLEAR MEDICINE.
  • $8,209 - Monday the 12th of March 2012
    Veterans Affairs Department
    757-COLUMBUS
    RADIOPHARMACEUTICALS FOR VISN 10
  • $80,238 - Friday the 2nd of March 2012
    Veterans Affairs Department
    552-DAYTON
    ESTIMATED PO FOR OCTOBER 2011 THRU MARCH 2012.
  • $80,238 - Tuesday the 20th of March 2012
    Veterans Affairs Department
    552-DAYTON
    ESTIMATED PO FOR OCTOBER 2011 THRU MARCH 2012.
  • $8,000 - Thursday the 27th of September 2012
    Veterans Affairs Department
    521-BIRMINGHAM
    RADIOISOTOPES - MOD 0001 TO INCREASE $8,000.00

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.